pyrazolanthrone has been researched along with mpi-0479605 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, Y; Daigo, Y; Dohi, K; Hashizume, H; Hato, Y; Higaki, M; Higashino, K; Ide, N; Iguchi, M; Inoue, M; Ishioka, Y; Itoh, T; Kanazawa, T; Kido, Y; Kusakabe, K; Maeda, M; Murai, H; Nakamura, Y; Okano, Y; Sakamoto, S; Sato, Y; Shiota, T; Tachibana, Y; Ueda, K; Yamamoto, T; Yasuo, K; Yoshizawa, H | 1 |
| Awrey, DE; Ban, F; Beletskaya, I; Chirgadze, NY; Edwards, LG; Feher, M; Green, E; Harris-Brandts, M; Hodgson, R; Huang, P; Kiarash, R; Lang, Y; Laufer, R; Leung, G; Li, SW; Lin, DC; Liu, Y; Luo, X; Mak, TW; Mao, G; Mason, JM; Nadeem, V; Ng, G; Pan, GJ; Patel, NK; Pauls, HW; Plotnikova, O; Qiu, W; Wei, X | 1 |
| Jiang, M; Li, C; Li, J; Liang, D; Liu, J; Sun, W; Wang, S; Yang, X; Zhang, C; Zhang, M; Zhou, X | 1 |
1 review(s) available for pyrazolanthrone and mpi-0479605
| Article | Year |
|---|---|
Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: A Medicinal chemistry perspective.
Topics: Antineoplastic Agents; Cell Cycle Proteins; Drug Design; Drug Resistance; Humans; M Phase Cell Cycle Checkpoints; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Spindle Apparatus; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2019 |
2 other study(ies) available for pyrazolanthrone and mpi-0479605
| Article | Year |
|---|---|
Indazole-based potent and cell-active Mps1 kinase inhibitors: rational design from pan-kinase inhibitor anthrapyrazolone (SP600125).
Topics: Animals; Anthracenes; Cell Cycle Proteins; Cell Line, Tumor; Crystallography, X-Ray; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Models, Molecular; Molecular Conformation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Rats; Structure-Activity Relationship | 2013 |
Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides.
Topics: Amides; Benzeneacetamides; Cell Cycle Proteins; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Humans; Indazoles; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Structure-Activity Relationship | 2014 |